J9043 Cabazitaxel - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Cabazitaxel

Brand Name:

Jevtana

Strength:

1 mg

HCPCS:

J9043

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Antimitotic Agent

Minor Drug Class:

Taxane

Oral (Y/N):

No

FDA Approval Year:

2010

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 2012

CMS Discontinuation Date:

Status:

In Use